N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population
Babizhayev, Mark A, Burke, Leslie, Micans, Philip, Richer, Stuart P
Published in Clinical interventions in aging (01.01.2009)
Published in Clinical interventions in aging (01.01.2009)
Get full text
Journal Article
N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients
Babizhayev, Mark A, Micans, Philip, Guiotto, Andrea, Kasus-Jacobi, Anne
Published in American journal of therapeutics (01.11.2009)
Published in American journal of therapeutics (01.11.2009)
Get more information
Journal Article